These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

597 related items for PubMed ID: 37021347

  • 1. Repurposing immune boosting and anti-viral efficacy of Parkia bioactive entities as multi-target directed therapeutic approach for SARS-CoV-2: exploration of lead drugs by drug likeness, molecular docking and molecular dynamics simulation methods.
    Dinata R, Nisa N, Arati C, Rasmita B, Uditraj C, Siddhartha R, Bhanushree B, Saeed-Ahmed L, Manikandan B, Bidanchi RM, Abinash G, Pori B, Khushboo M, Roy VK, Gurusubramanian G.
    J Biomol Struct Dyn; 2024; 42(1):43-81. PubMed ID: 37021347
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2.
    Muhseen ZT, Hameed AR, Al-Hasani HMH, Ahmad S, Li G.
    Molecules; 2021 Jan 28; 26(3):. PubMed ID: 33525411
    [Abstract] [Full Text] [Related]

  • 5. Some Flavolignans as Potent Sars-Cov-2 Inhibitors via Molecular Docking, Molecular Dynamic Simulations and ADME Analysis.
    Cetin A.
    Curr Comput Aided Drug Des; 2022 Jan 28; 18(5):337-346. PubMed ID: 35975852
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In Silico Screening of Some Active Phytochemicals to Identify Promising Inhibitors Against SARS-CoV-2 Targets.
    Alagarsamy V, Solomon VR, Murugesan S, Sundar PS, Muzaffar-Ur-Rehman MD, Chandu A, Aishwarya AD, Narendhar B, Sulthana MT, Ravikumar V.
    Curr Drug Discov Technol; 2024 Jan 28; 21(3):73-89. PubMed ID: 37861016
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein.
    Manjunathan R, Periyaswami V, Mitra K, Rosita AS, Pandya M, Selvaraj J, Ravi L, Devarajan N, Doble M.
    BMC Bioinformatics; 2022 May 16; 23(1):180. PubMed ID: 35578172
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Biflavonoids from Rhus succedanea as probable natural inhibitors against SARS-CoV-2: a molecular docking and molecular dynamics approach.
    Lokhande K, Nawani N, K Venkateswara S, Pawar S.
    J Biomol Struct Dyn; 2022 Jul 16; 40(10):4376-4388. PubMed ID: 33300454
    [Abstract] [Full Text] [Related]

  • 14. Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study.
    Shahbazi B, Mafakher L, Teimoori-Toolabi L.
    J Mol Model; 2022 Mar 05; 28(4):82. PubMed ID: 35249180
    [Abstract] [Full Text] [Related]

  • 15. SARS-CoV-2 proteases Mpro and PLpro: Design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations.
    Tumskiy RS, Tumskaia AV, Klochkova IN, Richardson RJ.
    Comput Biol Med; 2023 Feb 05; 153():106449. PubMed ID: 36586228
    [Abstract] [Full Text] [Related]

  • 16. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies.
    Azeem M, Mustafa G, Mahrosh HS.
    Int J Immunopathol Pharmacol; 2022 Feb 05; 36():3946320221142793. PubMed ID: 36442514
    [Abstract] [Full Text] [Related]

  • 17. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.
    Kumar N, Sood D, van der Spek PJ, Sharma HS, Chandra R.
    J Proteome Res; 2020 Nov 06; 19(11):4678-4689. PubMed ID: 32786685
    [Abstract] [Full Text] [Related]

  • 18. Plant derived active compounds as potential anti SARS-CoV-2 agents: an in-silico study.
    Kashyap D, Jakhmola S, Tiwari D, Kumar R, Moorthy NSHN, Elangovan M, Brás NF, Jha HC.
    J Biomol Struct Dyn; 2022 Nov 06; 40(21):10629-10650. PubMed ID: 34225565
    [Abstract] [Full Text] [Related]

  • 19. Multi-Targeted Molecular Docking and Drug-Likeness Evaluation of some Nitrogen Heterocyclic Compounds Targeting Proteins Involved in the Development of COVID-19.
    Hui LY, Mun CS, Sing LC, Rajak H, Karunakaran R, Ravichandran V.
    Med Chem; 2023 Nov 06; 19(3):297-309. PubMed ID: 35713125
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies.
    Abdizadeh R, Hadizadeh F, Abdizadeh T.
    J Biomol Struct Dyn; 2023 Nov 06; 41(13):5915-5945. PubMed ID: 35848354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.